VANI 1.30 Vivani Medical, Inc.
| Range: | 0.84-7.8 | Vol Avg: | 76978 | Last Div: | 0 | Changes: | 0.04 |
| Beta: | 3.6 | Cap: | 0.07B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Wed Nov 19 2014 | Empoloyees: | 36 | ||
| CUSIP: | 92854B109 | CIK: | 0001266806 | ISIN: | US92854B1098 | Country: | US |
| CEO: | Mr. Adam Mendelsohn Ph.D. | Website: | https://www.vivani.com | ||||
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
Stock Details
Positive 0.24
Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024
ALAMEDA, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “V...
businesswire.com·Mon Sep 23 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow